Stay updated on ONC-392 Safety, PK & Efficacy in Solid Tumors & NSCLC Clinical Trial
Sign up to get notified when there's something new on the ONC-392 Safety, PK & Efficacy in Solid Tumors & NSCLC Clinical Trial page.

Latest updates to the ONC-392 Safety, PK & Efficacy in Solid Tumors & NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision: v3.3.3 was added to the site footer and Revision: v3.3.2 was removed. The HHS Vulnerability Disclosure link in the footer was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedThe Record History now lists a new revision (v3.3.2) and removes v3.2.0, which are metadata updates to the page rather than changes to study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedRemoved the top notice about government funding and operating status; no other content changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check75 days agoChange DetectedThe new version updates the Study Status and Recruitment Status fields to reflect the trial's current state on the record history page. This informs users about whether the trial is actively recruiting and its overall progress.SummaryDifference0.1%

- Check97 days agoChange DetectedThe page is updated to v3.2.0 and adds a government operating-status notice, replacing the previous v3.1.0 reference.SummaryDifference10%

- Check104 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

Stay in the know with updates to ONC-392 Safety, PK & Efficacy in Solid Tumors & NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ONC-392 Safety, PK & Efficacy in Solid Tumors & NSCLC Clinical Trial page.